HighTower Advisors
ROIV icon

HighTower Advisors’s Roivant Sciences ROIV Stock Holding History

HighTower Advisors’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$932K Buy
33,664
+4,804
+17% +$123K ﹤0.01% 2232
2025
Q4 		$626K Buy
28,860
+3,673
+15% +$72.5K ﹤0.01% 2451
2025
Q3 		$381K Buy
25,187
+7,044
+39% +$87.2K ﹤0.01% 2836
2025
Q2 		$204K Buy
18,143
+4,211
+30% +$45.6K ﹤0.01% 3263
2025
Q1 		$141K Buy
13,932
+3,719
+36% +$40.2K ﹤0.01% 3283
2024
Q4 		$121K Buy
+10,213
New +$121K ﹤0.01% 3337
2023
Q1 		– Sell
-18,200
Closed -$146K – 3632
2022
Q4 		$146K Buy
+18,200
New +$101K ﹤0.01% 2865

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
QF
QVT Financial New York $1.27B AUM 148.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return